Volume 16, Issue 4 (Winter 2019)                   Sci J Iran Blood Transfus Organ 2019, 16(4): 270-279 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mahdaviani F, Ahmadi Iraqi I, Khalili M, Khosrowpour L, ٍEmyaei H, Moradabadi A, et al . Pattern of blood component utilization in Arak, Iran. Sci J Iran Blood Transfus Organ 2019; 16 (4) :270-279
URL: http://bloodjournal.ir/article-1-1300-en.html
Pattern of blood component utilization in Arak, Iran
F.S. Mahdaviani , I. Ahmadi Iraqi , M. Khalili , L. Khosrowpour , H. ٍEmyaei , A.R. Moradabadi , Sh. Abbasi , M. Khalili *
Keywords: Key words: Blood Transfusion, International Classification of Diseases, Iran
Full-Text [PDF 613 kb]   (1089 Downloads)     |   Abstract (HTML)  (3336 Views)
Full-Text:   (2345 Views)
References:
 
 
  1. Abdella Y, Pourfathollah AA, Slama H, Raouf M. The role of access to affordable and quality assured blood and blood products for achieving Universal Health Coverage. East Mediterr Health J 2018; 24(3): 235-6.
  2. Okocha C, Ogbenna AA, Ezeama N, Aneke J, Ezeh T. Pattern of blood procurement and utilization in a university hospital in Southeast Nigeria. Ann Trop Pathol 2019; 10: 63-7.
  3. Díaz MQ, Borobia AM, García Erce JA, Maroun-Eid C, Fabra S, Carcas A, et al. Appropriate use of red blood cell transfusion in emergency departments: a study in five emergency departments. Blood Transfus 2017; 15(3): 199-206.
  4. Zadsar M, Sadegh H, Naseranipoor M, Haji Beigi B, Mirrezaie S. Irradiation of blood products: one year experience in Tehran Blood Transfusion Center. Sci J Iran Blood Transfus Organ 2013; 10(3): 312-8. [Article in Farsi]
  5. Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2016; 10: CD002042.
  6. Derzon JH, Clarke N, Alford A, Gross I, Shander A, Thurer R. Restrictive Transfusion Strategy and Clinical Decision Support Practices for Reducing RBC Transfusion Overuse. Am J Clin Pathol 2019; 152(5): 544-57.
  7. Soril LJJ, Noseworthy TW, Dowsett LE, Memedovich K, Holitzki HM, Lorenzetti DL, et al. Behaviour modification interventions to optimise red blood cell transfusion practices: a systematic review and meta-analysis. BMJ Open 2018; 8(5): e019912.
  8. Kipkulei JC, Buziba N, Mining S, Jepngetich H. Demographic and Clinical Profiles of Blood Transfusion Recipients at a Teaching and Referral Hospital in Kenya. Open Journal of Blood Diseases 2019; 9(1): 30-40.
  9. Bosch MA,  Contreras E, Madoz P, Ortiz P, Pereira A, Pujol MM, et al. The epidemiology of blood component transfusion in Catalonia, Northeastern Spain. Transfusion 2011; 51(1): 105-16.
  10. Biggin, Warner P, Prescott R, McClelland B. A review of methods used in comprehensive, descriptive studies that relate red blood cell transfusion to clinical data. Transfusion 2010; 50(3): 711-8.
  11. Pitman JP, Wilkinson R, Liu Y, von Finckenstein B, Smit Sibinga CT, Lowrance DW, et al. Blood component use in a sub-Saharan African country: results of a 4-year evaluation of diagnoses associated with transfusion orders in Namibia. Transfus Med Rev 2015; 29(1): 45-51.
  12. Mafirakureva N, Khoza S, Hassall O, Faragher BE, Kajja I, Mvere DA, et al. Profiles of blood and blood component transfusion recipients in Zimbabwe. Blood Transfus 2015; 13(4): 600-9.
  13. Goncalez TT, Sabino EC, Capuani L, Liu J, Wright DJ, Walsh JH, et al. Blood transfusion utilization and recipient survival at Hospital das Clinicas in Sao Paulo, Brazil. Transfusion 2012; 52(4): 729-38.
  14. Cobain T, Vamvakas EC, Wells A, Titlestad K. A survey of the demographics of blood use. Transfus Med 2007; 17(1): 1-15.
  15. Ambroise MM, Ravichandran K, Ramdas A, Sekhar G. A study of blood utilization in a tertiary care hospital in South India. J Nat Sci Biol Med 2015; 6(1): 106-10.
  16. Javadzadeh Shahshahani H, Hatami H, Meraat N, Savabieh S. Epidemiology of blood component
    recipients in hospitals of Yazd, Iran. Transfus Med 2015; 25(1): 2-7.
  17. Maramazi Ghaflez B, Kaab Omeir H, Jalali Far M, Saki N, Torabizadeh Maatoghi J, Naderpour M. Study of rate and causes of blood components discard among Ahwaz's hospital. Sci J Iran Blood Transfus Organ 2014; 11(3): 197-206. [Article in Farsi]
  18. Vamvakas EC. Epidemiology of blood transfusion and forecasts of the demand for blood. In: Evidence-Based Practice of Transfusion Medicine. Bethesda: American Association of Blood Banks; 2001. p. 177-99.
  19. Tinegate H, Chattree S, Iqbal A, Plews D, Whitehead J, Wallis JP, et al. Ten-year pattern of red blood cell use in the North of England. Transfusion 2013; 53(3): 483-9.
  20. Okoroiwu HU, Okafor IM. Demographic characteristics of blood and blood components transfusion recipients and pattern of blood utilization in a tertiary health institution in southern Nigeria. BMC Hematol 2018; 18(1): 16.
  21. Borkent-Raven BA, Janssen MP, van der Poel CL, Schaasberg WP, Bonsel GJ, van Hout BA.. The PROTON study: profiles of blood product transfusion recipients in the Netherlands. Vox Sang 2010; 99(1): 54-64.
  22. Spahn DR, Goodnough LT. Alternatives to blood transfusion. Lancet 2013; 381(9880): 1855-65.
  23. de Dreuzy E, Bhukhai K, Leboulch P, Payen E. Current and future alternative therapies for beta-thalassemia major. Biomed J 2016; 39(1): 24-38.
  24. Rivella S, Rachmilewitz E. Future alternative therapies for β-thalassemia. Expert Rev Hematol 2009; 2(6): 685-97.
  25. Gharehbaghian A, Hatami H, Emami H, Bardeh M, Karimi G. Evaluation of blood utilization in Rasht . Sci J Iran Blood Transfus Organ 2010; 7(2): 101-8. [Article in Farsi]
  26. Mirzamani N, Molana A, Poorani E. Evaluation of appropriate usage of fresh frozen plasma: Results of a regional audit in Iran. Transfus Apher Sci 2009; 40(2): 109-13.
  27. Desai P, Navkudkar A, Rajadhyaksha SB. Evaluation of utilization pattern of fresh frozen plasma in a tertiary care oncology center. Glob J Transfus Med 2018; 3(2): 109-12.
  28. Sheikholeslami H, Kani C, Fallah-Abed P, Lalooha F, Mohammadi N. Transfusion audit of blood products using the World Health Organization Basic Information Sheet in Qazvin, Islamic Republic of Iran.
Eastern MediterraneanHealth Journal 2010; 16(12): 1257-62.
 
 
 
 
 

 
 
 
 
 
 
 
Sci J Iran Blood Transfus Organ 2019;16 (4): 270-279
Original Article
 
 

Pattern of blood component utilization in Arak, Iran
 
Mahdaviani F.S.1,2, Ahmadi Iraqi I.1,2, Khalili M.3, Khosrowpour L.4, Emyaei H.1,2,
 Moradabadi A.R.5, Abbasi Sh.3, Khalili M.1,2
 
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2Arak Blood Transfusion Center, Arak, Iran
3Islamic Azad University of Khomein Branch, Khomein, Iran
4Ayatollah Khansari Hospital, Arak University of Medical Sciences, Arak, Iran
5Arak University of Medical Sciences, Arak, Iran
 
Abstract
Background and Objectives
Blood transfusion in medical care is one of the main treatments. However, blood transfusion is not without risk. Investigating the patterns of blood products utilization can help improve blood products usage and predict future blood products demand. Therefore, in this study, the pattern of blood product utilization in Arak hospitals has been investigated.
 
Materials and Methods
In this descriptive cross-sectional study, four hospitals in Arak were selected and the desired information including type and amount of utilized blood products and thier relationship with patient characteristics such as age, gender, diagnosis of the disease were evaluated during the first 6 months of 1397 (according to Iranian Calendar). Diseases were classified based on the International Classification of Diseases, 10th. Edition (ICD-10).
 
Results
All 7300 patients, 54.4% of whom male, received 6928 RBC units, 3829 FFP units, 8196 random platelet units and 171 apheresis platelet units in all four hospitals. In all three types of utilized products (RBC, FFP, platelet), the recipient group with the age range of 41-64 years received the highest rate of blood products and the highest utilization of RBC, FFP, platelet  pertained to patients with neoplasm. The average utilization of RBC was 1.9 ± 2.05 units, FFP was 2.7 ± 2.35 units and platelet was 3.7±4.05 units, and the most utilized product in all four hospitals was RBC.
 
Conclusions 
The results of the current study represents the blood components utilization by age, sex and various diseases in Arak with regard to the relationship between the usage of blood components and the demographic pattern of the region. Therefore, the feasibility of using the obtained pattern in order to predict and plan for the blood components needed for this region based on the demographic pattern of Arak city will be possible.
 
Key words: Blood Transfusion, International Classification of Diseases, Iran
 
 
 
 
Received: 26 Aug 2019
Accepted:14 Oct  2019
 
 

Correspondence: Khalili M., PhD Student of Medical Biotechnology. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine and Arak Blood Transfusion Center.
Postal Code: 3813894881, Arak, Iran. Tel: (+9886) 32248031; Fax: (+9886) 32248032
E-mail: Mostafakhalili62@yahoo.com
Type of Study: Research | Subject: Blood Transfusion
Published: 2019/12/31
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Scientific Journal of Iran Blood Transfus Organ

Designed & Developed by : Yektaweb